Looking at the data side by side reveals there is much work to do, and why understanding the entourage effect is essential.
Usona Follows COMPASS in Receiving Breakthrough Therapy Designation for Psilocybin to Treat Depression
This means the FDA will work to expedite the development and review of psilocybin so it can get to patients with major depressive disorder as soon as possible.
From constipation to cognition, serotonin receptors play many roles in addition to the psychedelic effect.
Researchers isolate ß-carbolines from several species of Psilocybe.
Yes, and it may work via 5-HT2A as well as the cannabinoid receptors.
As psychedelic research moves ahead, some have started to identify several topics of significant interest to women.
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
The center aims to quantify the chemicals in magic mushrooms and possibly identify new psychedelic molecules in them.
This is the first time psilocybin has been produced from a prokaryotic organism.
Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.